Search

everythinglearnresearchcommunity

for

Search:↓

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Smoking increases early hair loss risk in men; quitting may help prevent it.

Testosterone reduces heart damage and inflammation after injury.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Some birth control pills increase young women's risk of blood clots more than others.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Wnt1/βcatenin signaling is crucial for heart repair after injury.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Aromatase gene variation may increase female hair loss risk.

Some birth control pills have a higher risk of blood clots than others.

Using topical minoxidil for baldness can cause heart problems, especially in those with heart disease.

Fibroblast Growth Factor-9 (FGF-9) can help improve heart function in diabetic mice after a heart attack by reducing inflammation and harmful changes to the heart's structure.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Vitamin D levels do not affect the risk of developing alopecia areata.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Minoxidil lowers blood pressure and increases heart efficiency, but may raise lung artery pressure in some people.